CorMedix Inc. announced the appointment of Greg Duncan to its Board of Directors. Greg will replace Dr. Mehmood Khan, who is stepping down from the Board due to policies in place with his new role within an investment organization. Greg Duncan Greg currently serves as the Chairman and CEO of Virios Therapeutics. Prior to joining his current company earlier this year, Greg served as President and CEO of Celtaxsys. Greg spent the majority of his career in senior leadership roles in commercial stage pharmaceutical companies.